Authors:
COMENZO RL
VOSBURGH E
FALK RH
SANCHORAWALA V
REISINGER J
DUBREY S
DEMBER LM
BERK JL
AKPEK G
LAVALLEY M
OHARA C
ARKIN CF
WRIGHT DG
SKINNER M
Citation: Rl. Comenzo et al., DOSE-INTENSIVE MELPHALAN WITH BLOOD STEM-CELL SUPPORT FOR THE TREATMENT OF AL (AMYLOID LIGHT-CHAIN) AMYLOIDOSIS - SURVIVAL AND RESPONSES IN25 PATIENTS, Blood, 91(10), 1998, pp. 3662-3670
Authors:
MENDES LA
REISINGER JR
DUBREY SW
COMENZO R
VOSBURGH E
SANCHORAWALA V
LAVALLEY M
SKINNER M
FALK RH
Citation: La. Mendes et al., ECHOCARDIOGRAPHIC IDENTIFICATION OF CARDIAC AMYLOIDOSIS PATIENTS CAPABLE OF UNDERGOING INTENSIVE TREATMENT WITH INTRAVENOUS MELPHALAN THERAPY, Journal of the American College of Cardiology, 31(2), 1998, pp. 109-109
Authors:
SKINNER M
FINN K
COMENZO R
VOSBURGH E
SANCHORAWALA V
AKPEK G
SPELLANE K
FALK R
DEMBER L
BERK J
MURAKAMI A
LIBBEY C
WRIGHT D
Citation: M. Skinner et al., 4 YEAR EXPERIENCE WITH HIGH-DOSE IV MELPHALAN AND PERIPHERAL STEM-CELL RESCUE IN AL AMYLOIDOSIS, Arthritis and rheumatism, 41(9), 1998, pp. 1205-1205
Authors:
REISINGER JR
MENDES LA
DUBREY SW
COMENZO R
VOSBURGH E
SANCHORAWALA V
SKINNER M
FALK RH
Citation: Jr. Reisinger et al., CARDIAC INVOLVEMENT IN AL AMYLOIDOSIS IS A MARKER OF CARDIAC AND NONCARDIAC DEATH IN PATIENTS UNDERGOING TREATMENT WITH INTENSIVE INTRAVENOUS MELPHALAN THERAPY, Circulation, 96(8), 1997, pp. 3901-3901
Authors:
FANHAVARD P
SANCHORAWALA V
OH J
MOSER EM
SMITH SP
Citation: P. Fanhavard et al., CONCURRENT USE OF FOSCARNET AND CIPROFLOXACIN MAY INCREASE THE PROPENSITY FOR SEIZURES, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 869-872